NorthExcel Associates represented Orbicular Pharmaceutical Technologies in relation to divestment of its 40% equity stake in Aleor Dermaceuticals Limited
NorthExcel Associates represented Orbicular Pharmaceutical Technologies in relation to divestment of its 40% stake in Aleor Dermaceuticals Limited to Alembic Pharmaceuticals Limited.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at [email protected] mentioning your firm’s name, lawyers involved (including designation) and client represented.
